Used in pharmaceutical synthesis as an intermediate for developing angiotensin II receptor antagonists, particularly in the production of antihypertensive drugs. Its structure supports binding to specific biological targets involved in blood pressure regulation. Also investigated for use in developing anti-inflammatory and antioxidant agents due to the benzo[d]imidazole moiety’s biological activity. Employed in research settings to design new compounds with improved metabolic stability and receptor selectivity.